Center-Authored Papers

Filters: Author is Crawford, Jeffrey  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Young Adult
Zeliadt SB, Sekaran NK, Hu EY, Slatore CC, Au DH, Backhus L, Wu DY, Crawford J, Lyman GH, Dale DC.  2011.  Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(10):1726-32. Abstract
Vincristine
Lyman GH, Dale DC, Friedberg J, Crawford J, Fisher RI.  2004.  Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(21):4302-11. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Veterans
Zeliadt SB, Sekaran NK, Hu EY, Slatore CC, Au DH, Backhus L, Wu DY, Crawford J, Lyman GH, Dale DC.  2011.  Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(10):1726-32. Abstract
United States
Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH.  2008.  Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):109-18. Abstract
Griggs JJ, Culakova E, Sorbero MES, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(18):2522-7. Abstract
Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J et al..  2009.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(1):64-83.
Lyman GH, Dale DC, Friedberg J, Crawford J, Fisher RI.  2004.  Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(21):4302-11. Abstract
Shayne M, Crawford J, Dale DC, Culakova E, Lyman GH.  2006.  Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.. Breast cancer research and treatment. 100(3):255-62. Abstract
Lyman GH, Dale DC, Crawford J.  2003.  Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(24):4524-31. Abstract
Zeliadt SB, Sekaran NK, Hu EY, Slatore CC, Au DH, Backhus L, Wu DY, Crawford J, Lyman GH, Dale DC.  2011.  Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(10):1726-32. Abstract
Griggs JJ, Culakova E, Sorbero MES, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(3):277-84. Abstract
Treatment Outcome
Kuderer NM, Dale DC, Crawford J, Lyman GH.  2007.  Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(21):3158-67. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Griggs JJ, Culakova E, Sorbero MES, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.  2007.  Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(18):2522-7. Abstract
Lyman GH, Dale DC, Wolff DA, Culakova E, Poniewierski MS, Kuderer NM, Crawford J.  2010.  Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2914-24. Abstract
Cosler LE, Sivasubramaniam V, Agboola O, Crawford J, Dale D, Lyman GH.  2005.  Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 8(1):47-52. Abstract
Lyman GH, Dale DC, Friedberg J, Crawford J, Fisher RI.  2004.  Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(21):4302-11. Abstract
Shayne M, Crawford J, Dale DC, Culakova E, Lyman GH.  2006.  Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.. Breast cancer research and treatment. 100(3):255-62. Abstract
Time Factors
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Cosler LE, Eldar-Lissai A, Culakova E, Kuderer NM, Dale D, Crawford J, Lyman GH.  2007.  Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective.. PharmacoEconomics. 25(4):343-51. Abstract
Thrombocytopenia
Shayne M, Culakova E, Wolff D, Poniewierski MS, Dale DC, Crawford J, Lyman GH.  2009.  Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.. Cancer. 115(22):5319-28. Abstract
Taxoids
Lyman GH, Dale DC, Tomita D, Whittaker S, Crawford J.  2013.  A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting.. Breast cancer research and treatment. 139(3):863-72. Abstract
Survival Rate
Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH.  2006.  Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.. Cancer. 106(10):2258-66. Abstract
Zeliadt SB, Sekaran NK, Hu EY, Slatore CC, Au DH, Backhus L, Wu DY, Crawford J, Lyman GH, Dale DC.  2011.  Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(10):1726-32. Abstract